Pandion Therapeutics Inc
(PAND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 219,891 | 15,970 | 10,172 |
| Receivables | 950 | 1,035 | N/A |
| TOTAL | $223,939 | $19,965 | $11,459 |
| Non-Current Assets | |||
| PPE Net | 3,423 | 1,054 | 765 |
| Other Non-Current Assets | 502 | 0 | 0 |
| TOTAL | $3,925 | $1,054 | $765 |
| Total Assets | $227,864 | $21,019 | $12,224 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,775 | 1,207 | 951 |
| Accrued Expenses | 3,282 | 1,455 | 1,343 |
| TOTAL | $8,856 | $7,027 | $2,294 |
| Non-Current Liabilities | |||
| Long Term Debt | 0 | 3,676 | 2,010 |
| Deferred Revenues | 3,799 | 4,365 | N/A |
| Other Non-Current Liabilities | 520 | 47,052 | 24,977 |
| TOTAL | $4,278 | $56,781 | $26,987 |
| Total Liabilities | $13,134 | $63,808 | $29,281 |
| Shareholders' Equity | |||
| Common Shares | 28 | N/A | N/A |
| Retained earnings | -85,975 | -42,961 | -17,109 |
| Other shareholders' equity | 0 | 172 | 0 |
| TOTAL | $214,730 | $-42,789 | $-17,057 |
| Total Liabilities And Equity | $227,864 | $21,019 | $12,224 |